Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2339${count})

  • Improved Biomarkers and Clinical Outcome Measures, 2019
    Multimodal MR Imaging of the Midbrain for Early Parkinson’s Progression

    Study Rationale:
    Parkinson’s disease (PD) is marked by the loss of dopamine neurons in part of the midbrain, a section toward the base of the brain that serves important functions in movement. In the...

  • Therapeutic Pipeline Program, 2019
    Miro1-targeting Drug Discovery for Parkinson's Disease

    Study Rationale:
    There is mounting evidence for involvement of mitochondrial biology in the pathogenesis of Parkinson’s disease (PD). Alterations in mitochondrial dynamics and distribution have been...

  • Therapeutic Pipeline Program, 2019
    Screening for Precision Parkin Activators

    Study Rationale:
    Defects in the protein parkin cause the loss of nerve cells in the brain and are responsible for many cases of young-onset Parkinson's disease that develops before 50 years of age. We...

  • Research Grant, 2019
    Patient Reports on Cannabis Use in Parkinson's Disease

    Study Rationale:
    Medical marijuana (cannabis) is now legal in 47 states, and recreational use is legal in nine. Interest in cannabis for treating Parkinson’s disease (PD) is rapidly increasing...

  • Research Grant, 2019
    Pathogenesis of the Virome in Parkinson’s Disease

    Study Rationale:
    Numerous studies have implicated viruses as causal factors or potential triggers for Parkinson’s disease (PD). Our study will provide a comprehensive understanding of all the viral...

  • Aligning Science Across Parkinson's, 2019
    Global Parkinson’s Genetics Program (GP2)
    GP2 Logo

    GP2 is a resource of the Aligning Science Across Parkinson's (ASAP) InitiativeIt is an ambitious five-year program to genotype >150,000 volunteers around the world to further understand the genetic...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.